Citations

Showing 10 of 108083 citations.

Diagnostic Imaging in the Evaluation of Asymptomatic Microhematuria: Systematic Review and Meta-analysis
Taylor, Jacob , Souter, Lesley , Barocas, Daniel A. , Boorjian, Stephen A. , Raman, Jay D. , Lotan, Yair

Mayo Clinic

Journal of Urology | March 8, 2023 | Volume: 209 | Issue: 6 | Pages: 1099-1106

10.1097/ju.0000000000003395 | PMID 36883858 Get It

T-Cell Prolymphocytic Leukemia With t(X;14)(q28;q11.2): A Clinicopathologic Study of 15 Cases
Hu, Zhihong , Xu, Mina L. , Ji, Yuan , Peker, Deniz , Shao, Lina , Mai, Brenda , Rios, Adan, Hu, Shimin , Wang, Wei , Hu, Shimin , Yuan, Ji , Medeiros, L. Jeffrey , Tang, Zhenya , Thakral, Beenu

Mayo Clinic

American Journal of Clinical Pathology | March 8, 2023 | Volume: 159 | Issue: 4 | Pages: 325-336

10.1093/ajcp/aqac166 | PMID 36883805 Get It

AbstractObjectivesT-cell prolymphocytic leukemia (T-PLL) is a rare mature T-cell leukemia usually characterized by inv(14)(q11.2q32)/t(14;14)(q11.2;q32). In this study, we aimed to investigate the clinicopathologic features and molecular profile of T-PLL associated with t(X;14)(q28;q11.2).MethodsThe study group included 10 women and 5 men with a median age of 64 years. All 15 patients had a diagnosis of T-PLL with t(X;14)(q28;q11.2).ResultsAll 15 patients had lymphocytosis at initial diagnosis. Morphologically, the leukemic cells had features of prolymphocytes in 11 patients, small cell variant in 3, and cerebriform variant in 1. All 15 patients had hypercellular bone marrow with an interstitial infiltrate in 12 (80%) cases. By flow cytometry, the leukemic cells were surface CD3+/CD5+/CD7+/CD26+/CD52+/TCR α/β+ in 15 (100%) cases, CD2+ in 14 (93%) cases, CD4+/CD8+ in 8 (53%) cases, CD4+/CD8– in 6 (40%) cases, and CD4–/CD8 + in 1 (7%) case. At the cytogenetic level, complex karyotypes with t(X;14)(q28;q11.2) were seen in all 15 patients assessed. Mutational analysis showed mutations of JAK3 in 5 of 6 and STAT5B p.N642H in 2 of 6 patients. Patients received variable treatments, including 12 with alemtuzumab. After a median follow-up of 17.2 months, 8 of 15 (53%) patients died.ConclusionsT-PLL with t(X;14)(q28;q11.2) frequently shows a complex karyotype and mutations involving JAK/STAT pathway, and it is an aggressive disease with a poor outcome.
Interactive enhancer hubs (iHUBs) mediate transcriptional reprogramming and adaptive resistance in pancreatic cancer
Hamdan, Feda H. , Abdelrahman, Amro M. , Kutschat, Ana P. , Wang, Xin , Ekstrom, Thomas L. , Jalan‐Sakrikar, Nidhi , Wippel, Catherine Wegner, Taheri, Negar , Tamon, Liezel, Kopp, Waltraut, Aggrey-Fynn, Joana , Bhagwate, Aditya , Lynch, Isaac, Kosinsky, Robyn Laura , Gaedcke, Jochen , Hahn, Stephan A. , Graham, Rondell, Najafova, Zeynab , Heßmann, Elisabeth , Truty, Mark J. , Johnsen, Steven A. , Kutschat, Ana Patricia , Wegner Wippel, Catherine, Bhagwate, Aditya V., Alva-Ruiz, Roberto, Yonkus, Jennifer, Hahn, Stephan A , Siveke, Jens , Johnsen, Steven A , Najafova, Zeynab , Kosinsky, Robyn Laura , Abdelrahman, Amro M , Sakrikar, Nidhi Jalan , Alva‐Ruiz, Roberto , Lynch, Isaac, Yonkus, Jennifer A.

Mayo Clinic

Gut | March 8, 2023 | Volume: 72 | Issue: 6 | Pages: 1174-1185

10.1136/gutjnl-2022-328154 | PMID 36889906 Get It

Objective Pancreatic ductal adenocarcinoma (PDAC) displays a remarkable propensity towards therapy resistance. However, molecular epigenetic and transcriptional mechanisms enabling this are poorly understood. In this study, we aimed to identify novel mechanistic approaches to overcome or prevent resistance in PDAC. Design We used in vitro and in vivo models of resistant PDAC and integrated epigenomic, transcriptomic, nascent RNA and chromatin topology data. We identified a JunD-driven subgroup of enhancers, called interactive hubs (iHUBs), which mediate transcriptional reprogramming and chemoresistance in PDAC. Results iHUBs display characteristics typical for active enhancers (H3K27ac enrichment) in both therapy sensitive and resistant states but exhibit increased interactions and production of enhancer RNA (eRNA) in the resistant state. Notably, deletion of individual iHUBs was sufficient to decrease transcription of target genes and sensitise resistant cells to chemotherapy. Overlapping motif analysis and transcriptional profiling identified the activator protein 1 (AP1) transcription factor JunD as a master transcription factor of these enhancers. JunD depletion decreased iHUB interaction frequency and transcription of target genes. Moreover, targeting either eRNA production or signaling pathways upstream of iHUB activation using clinically tested small molecule inhibitors decreased eRNA production and interaction frequency, and restored chemotherapy responsiveness in vitro and in vivo. Representative iHUB target genes were found to be more expressed in patients with poor response to chemotherapy compared with responsive patients. Conclusion Our findings identify an important role for a subgroup of highly connected enhancers (iHUBs) in regulating chemotherapy response and demonstrate targetability in sensitisation to chemotherapy.
Utility of 3D Modeling in Complex Upper Tract Reconstruction: Robot-Assisted Ureteropelvicostomy of Native Ureter to Transplant Renal Pelvis
Kemble, Jayson , Bearrick, Elizabeth , Anderson, Katherine T. , Findlay, Bridget L. , Viers, Boyd R.

Mayo Clinic

Videourology™ | March 8, 2023 | Volume: 37 | Issue: 1 | Pages: No page available

10.1089/vid.2022.0068 Get It

Clinical History: The case is a 17-year-old boy with a history of bilateral grade 4 vesicoureteral reflux and end-stage renal disease who underwent a living-unrelated donor renal transplantation in November 2021. He presented in June 2022 with vague abdominal pain and creatinine 4.3 mg/dL. Physical Examination: Transplant biopsy showed no evidence of acute rejection. Antegrade nephrostogram at the time of nephrostomy tube placement demonstrated hydronephrosis and a focal stricture of the proximal transplant ureter. His anatomy was further complicated because of prior ligation of his native distal right ureter at the time of transplant and intraperitoneal location of his transplant kidney through a peritoneal window. Diagnosis: Focal proximal stricture of transplant ureter. Intervention: Given the complex anatomy, a 3D-printed anatomical model was created to facilitate surgical planning. The 3D model highlighted a complex trajectory of the proximal ureter and strictured segment directly posterior to the transplant hilar vessels. In addition, the transplant kidney was directly overlying the dome of the bladder because of its intraperitoneal location. Given these anatomic considerations, the patient underwent an uncomplicated robot-assisted ureteropelvicostomy between his native left ureter and transplant renal pelvis. Follow-Up/Outcomes: Total robotic operative time was 2 hours 17 minutes. He was dismissed on postoperative day 1 with a creatinine nadir equivalent to his post-transplant baseline at 10-week follow-up. 3D-printed models have utility in select cases with complex anatomy. These models facilitate accurate regional and spatial anatomy of critical structures to enable effective operative planning. No competing financial interests exist. Patient consent statement: Patient consented to the use of nonidentifiable intraoperative photography and video recording for the purpose of medical education and publication in professional journals. Source of 3D model: Mayo clinic 3D Anatomic Modeling Laboratory. Authors have received and archived patient consent for video recording/publication in advance of video recording of procedure. No funding was received for this article. Music: All music was from Pixabay.com, royalty free. Runtime of video: 04 mins 58 secs
Endoscopic Urethral Stump Closure with a Novel Suture Device
Kemble, Jayson , Balzano, Felicia, Warner, Jonathan N. , Kemble, Jayson P , Findlay, Bridget L.

Mayo Clinic

Videourology™ | March 8, 2023 | Volume: 37 | Issue: 1 | Pages: No page available

10.1089/vid.2022.0067 Get It

Clinical History: A 60-year-old man with a history of muscle invasive small cell carcinoma of the bladder underwent robot-assisted radical cystectomy with pelvic lymph node dissection and Indiana pouch creation. He underwent aspiration and endoscopic urethral fulguration for a symptomatic lymphocele without improvement. Physical Examination: Clear fluid draining per urethra. CT of abdomen/pelvis showed unchanged loculated fluid collections within the dependent pelvis 2 months after aspiration and urethral fulguration. Diagnosis: Pelvic lymphocele with drainage per urethra. Intervention: Fulguration and closure of the urethral stump using a laparoscopic suture device (RD-180; LSI Solutions, Rochester, NY) and novel endoscopic sheath (JNW Urtract TM ; LSI Solutions). Before surgery, a pigtail drain was placed in the pelvic fluid collection. The proximal stump was fulgurated using the bipolar plasma band through a 27F cystourethroscope (Olympus Surgical Technologies America, Westborough, MA) to facilitate scarring. The stump was closed using the RD-180 under direct observation in a figure of eight manner both proximally at the opening and 1 cm distally. Knots were fashioned using the Ti-Knot fastener (LSI Solutions). Total operative time 37 minutes. Follow-Up/Outcomes: Patient was dismissed same-day following surgery. CT scan 2 months postoperatively demonstrated resolution of pelvic fluid collection, and his drain was removed. He remains asymptomatic without recurrence or urethral drainage 4 months postoperatively. To our knowledge, this is the first described case of endoscopic closure of a urethral stump in the setting of persistent drainage from a pelvic lymphocele. Fulguration with endoscopic closure using a novel device is both a safe and efficacious alternative to performing urethral fulguration alone. No competing financial interests exist. No funding was received for this article. Patient consent statement: Patient consented to the use of nonidentifiable intraoperative photography and video recording for the purpose of medical education and publication in professional journals. Authors have received and archived patient consent for video recording/publication in advance of video recording of procedure. Music: All music was from Pixabay.com, royalty free. Runtime of video: 4 mins 4 secs
Muscle stem cells contribute to long‐term tissue repletion following surgical sepsis
Schmitt, R. , Arneson‐Wissink, Paige C. , Datta, Srijani, Ducharme, Alexandra M. , Doles, Jason D. , Schmitt, Rebecca E, Dasgupta, Aneesha , Arneson-Wissink, Paige C, Doles, Jason D , Ducharme, Alexandra

Mayo Clinic

Journal of Cachexia, Sarcopenia and Muscle | March 8, 2023 | Volume: 14 | Issue: 3 | Pages: 1424-1440

10.1002/jcsm.13214 | PMID 36883680 Get It

AbstractBackgroundOver the past decade, advances in sepsis identification and management have resulted in decreased sepsis mortality. This increase in survivorship has highlighted a new clinical obstacle: chronic critical illness (CCI), for which there are no effective treatment options. Up to half of sepsis survivors suffer from CCI, which can include multi‐organ dysfunction, chronic inflammation, muscle wasting, physical and mental disabilities, and enhanced frailty. These symptoms prevent survivors from returning to regular day‐to‐day activities and are directly associated with poor quality of life.MethodsMice were subjected to cecal ligation and puncture (CLP) with daily chronic stress (DCS) as an in vivo model to study sepsis late‐effects/sequelae on skeletal muscle components. Longitudinal monitoring was performed via magnetic resonance imaging, skeletal muscle and/or muscle stem cell (MuSCs) assays (e.g., post‐necropsy wet muscle weights, minimum Feret diameter measurements, in vitro MuSC proliferation and differentiation, number of regenerating myofibres and numbers of Pax7‐positive nuclei per myofibre), post‐sepsis whole muscle metabolomics and MuSC isolation and high‐content transcriptional profiling.ResultsWe report several findings supporting the hypothesis that MuSCs/muscle regeneration are critically involved in post‐sepsis muscle recovery. First, we show that genetic ablation of muscle stem cells (MuSCs) impairs post‐sepsis muscle recovery (maintenance of 5–8% average lean mass loss compared with controls). Second, we observe impaired MuSCs expansion capacity and morphological defects at 26 days post‐sepsis compared with control MuSCs (P < 0.001). Third, when subjected to an experimental muscle injury, sepsis‐recovered mice exhibited evidence of impaired muscle regeneration compared with non‐septic mice receiving the same muscle injury (CLP/DCS injured mean minimum Feret is 92.1% of control injured, P < 0.01). Fourth, we performed a longitudinal RNA sequencing study on MuSCs isolated from post‐sepsis mice and found clear transcriptional differences in all post‐sepsis samples compared with controls. At Day 28, CLP/DCS mice satellite cells have multiple altered metabolic pathways, such as oxidative phosphorylation, mitochondrial dysfunction, sirtuin signalling and oestrogen receptor signalling, compared with controls (P < 0.001).ConclusionsOur data show that MuSCs and muscle regeneration are required for effective post‐sepsis muscle recovery and that sepsis triggers morphological, functional, and transcriptional changes in MuSCs. Moving forward, we strive to leverage a more complete understanding of post‐sepsis MuSC/regenerative defects to identify and test novel therapies that promote muscle recovery and improve quality of life in sepsis survivors.
Default mode network failure and neurodegeneration across aging and amnestic and dysexecutive Alzheimer’s disease
Corriveau‐Lecavalier, Nick , Gunter, Jeffrey L. , Kamykowski, Michael G. , Dicks, Ellen , Botha, Hugo , Kremers, Walter K. , Graff‐Radford, Jonathan , Wiepert, Daniela A. , Schwarz, Christopher G. , Yacoub, Essa , Knopman, David S. , Boeve, Bradley F. , Uǧurbil, Kǎmil , Petersen, Ronald C. , Jack, Clifford R. , Terpstra, Melissa , Jones, David T. , Knopman, David S. , Kamykowski, Michael, Jack, Clifford R , Schwarz, Christopher G , Boeve, Brad , Botha, Hugo , Jones, David T , Corriveau-Lecavalier, Nick , Kremers, Walter K

Mayo Clinic

Brain Communications | March 8, 2023 | Volume: 5 | Issue: 2 | Pages: No page available

10.1093/braincomms/fcad058 | PMID 37013176 Get It

AbstractFrom a complex systems perspective, clinical syndromes emerging from neurodegenerative diseases are thought to result from multiscale interactions between aggregates of misfolded proteins and the disequilibrium of large-scale networks coordinating functional operations underpinning cognitive phenomena. Across all syndromic presentations of Alzheimer’s disease, age-related disruption of the default mode network is accelerated by amyloid deposition. Conversely, syndromic variability may reflect selective neurodegeneration of modular networks supporting specific cognitive abilities. In this study, we leveraged the breadth of the Human Connectome Project-Aging cohort of non-demented individuals (N = 724) as a normative cohort to assess the robustness of a biomarker of default mode network dysfunction in Alzheimer’s disease, the network failure quotient, across the aging spectrum. We then examined the capacity of the network failure quotient and focal markers of neurodegeneration to discriminate patients with amnestic (N = 8) or dysexecutive (N = 10) Alzheimer’s disease from the normative cohort at the patient level, as well as between Alzheimer’s disease phenotypes. Importantly, all participants and patients were scanned using the Human Connectome Project-Aging protocol, allowing for the acquisition of high-resolution structural imaging and longer resting-state connectivity acquisition time. Using a regression framework, we found that the network failure quotient related to age, global and focal cortical thickness, hippocampal volume, and cognition in the normative Human Connectome Project-Aging cohort, replicating previous results from the Mayo Clinic Study of Aging that used a different scanning protocol. Then, we used quantile curves and group-wise comparisons to show that the network failure quotient commonly distinguished both dysexecutive and amnestic Alzheimer’s disease patients from the normative cohort. In contrast, focal neurodegeneration markers were more phenotype-specific, where the neurodegeneration of parieto-frontal areas associated with dysexecutive Alzheimer’s disease, while the neurodegeneration of hippocampal and temporal areas associated with amnestic Alzheimer’s disease. Capitalizing on a large normative cohort and optimized imaging acquisition protocols, we highlight a biomarker of default mode network failure reflecting shared system-level pathophysiological mechanisms across aging and dysexecutive and amnestic Alzheimer’s disease and biomarkers of focal neurodegeneration reflecting distinct pathognomonic processes across the amnestic and dysexecutive Alzheimer’s disease phenotypes. These findings provide evidence that variability in inter-individual cognitive impairment in Alzheimer’s disease may relate to both modular network degeneration and default mode network disruption. These results provide important information to advance complex systems approaches to cognitive aging and degeneration, expand the armamentarium of biomarkers available to aid diagnosis, monitor progression and inform clinical trials.
Unique plasma metabolite signature for adolescents with Klinefelter syndrome reveals altered fatty acid metabolism
Davis, Shanlee , Urban, Rhianna , D’Alessandro, Angelo , Reisz, Julie A. , Chan, Christine L. , Baker, Peter R. , Davis, Shanlee M , Kelsey, Megan Moriarty , Howell, Susan , Tartaglia, Nicole R. , Zeitler, Philip Scott

Mayo Clinic

Endocrine Connections | March 8, 2023 | Volume: 12 | Issue: 5 | Pages: No page available

10.1530/ec-22-0523 | PMID 36884262 Get It

Conditions related to cardiometabolic disease, including metabolic syndrome and type 2 diabetes, are common among men with Klinefelter syndrome (KS). The molecular mechanisms underlying this aberrant metabolism in KS are largely unknown, although there is an assumption that chronic testosterone deficiency plays a role. This cross-sectional study compared plasma metabolites in 31 pubertal adolescent males with KS to 32 controls of similar age (14 ± 2 years), pubertal stage, and body mass index z -score of 0.1 ± 1.2 and then between testosterone-treated ( n = 16) and untreated males with KS. The plasma metabolome in males with KS was distinctly different from that in controls, with 22% of measured metabolites having a differential abundance and seven metabolites nearly completely separating KS from controls (area under the curve > 0.9, P < 0.0001). Multiple saturated free fatty acids were higher in KS, while mono- and polyunsaturated fatty acids were lower, and the top significantly enriched pathway was mitochondrial β-oxidation of long-chain saturated fatty acids (enrichment ratio 16, P < 0.0001). In contrast, there were no observed differences in metabolite concentrations between testosterone-treated and untreated individuals with KS. In conclusion, the plasma metabolome profile in adolescent males with KS is distinctly different from that in males without KS independent of age, obesity, pubertal development, or testosterone treatment status and is suggestive of differences in mitochondrial β-oxidation.
MT‐ATP6 mitochondrial disease identified by newborn screening reveals a distinct biochemical phenotype
Tise, Christina G. , Verscaj, Courtney P. , Mendelsohn, Bryce A. , Woods, Jeremy D. , Lee, Chung U. , Enns, Gregory M. , Stander, Zinandré, Cowan, Tina M. , Cusmano‐Ozog, Kristina , Hall, Patricia

Mayo Clinic

American Journal of Medical Genetics Part A | March 8, 2023 | Volume: 191 | Issue: 6 | Pages: 1492-1501

10.1002/ajmg.a.63159 | PMID 36883293 Get It

AbstractAlthough decreased citrulline is used as a newborn screening (NBS) marker to identify proximal urea cycle disorders (UCDs), it is also a feature of some mitochondrial diseases, including MT‐ATP6 mitochondrial disease. Here we describe biochemical and clinical features of 11 children born to eight mothers from seven separate families who were identified with low citrulline by NBS (range 3–5 μM; screening cutoff >5) and ultimately diagnosed with MT‐ATP6 mitochondrial disease. Follow‐up testing revealed a pattern of hypocitrullinemia together with elevated propionyl‐(C3) and 3‐hydroxyisovaleryl‐(C5‐OH) acylcarnitines, and a homoplasmic pathogenic variant in MT‐ATP6 in all cases. Single and multivariate analysis of NBS data from the 11 cases using Collaborative Laboratory Integrated Reports (CLIR; https://clir.mayo.edu) demonstrated citrulline <1st percentile, C3 > 50th percentile, and C5‐OH >90th percentile when compared with reference data, as well as unequivocal separation from proximal UCD cases and false‐positive low citrulline cases using dual scatter plots. Five of the eight mothers were symptomatic at the time of their child(ren)'s diagnosis, and all mothers and maternal grandmothers evaluated molecularly and biochemically had a homoplasmic pathogenic variant in MT‐ATP6, low citrulline, elevated C3, and/or elevated C5‐OH. All molecularly confirmed individuals (n = 17) with either no symptoms (n = 12), migraines (n = 1), or a neurogenic muscle weakness, ataxia, and retinitis pigmentosa (NARP) phenotype (n = 3) were found to have an A or U mitochondrial haplogroup, while one child with infantile‐lethal Leigh syndrome had a B haplogroup.
Electrophysiological effects of BDNF and TrkB signaling at type-identified diaphragm neuromuscular junctions
Mantilla, Carlos B. , Ermilov, Leonid G., Greising, Sarah M. , Zhan, Wen‐Zhi, Sieck, Gary C. , Gransee, Heather M , Sieck, Gary , Mantilla, Carlos B , Gransee, Heather M.

Mayo Clinic

Journal of Neurophysiology | March 8, 2023 | Volume: 129 | Issue: 4 | Pages: 781-792

10.1152/jn.00015.2023 | PMID 36883761 Get It

Neurotrophin brain-derived neurotrophic factor (BDNF) enhances neuromuscular transmission via activation of tropomyosin-related kinase receptor B (TrkB). Rat phrenic nerve-diaphragm muscle preparations were used to determine the rapid effect of BDNF on synaptic quantal release during repetitive stimulation. BDNF treatment significantly enhanced quantal release at all fiber types. BDNF increased synaptic vesicle cycling (measured using FM4-64 fluorescence uptake); conversely, inhibiting BDNF/TrkB signaling decreased FM4-64 uptake.